Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.

× No keyword cloud information.

14 in total

1. A pharmacokinetic model for high-dose methotrexate infusions in man.

Authors: S D Reich; N R Bachur; R H Goebel; M Berman
Journal: J Pharmacokinet Biopharm Date: 1977-10

2. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Authors: W E Evans; C B Pratt; R H Taylor; L F Barker; W R Crom
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

Review 3. Clinical pharmacokinetics of methotrexate.

Authors: D D Shen; D L Azarnoff
Journal: Clin Pharmacokinet Date: 1978 Jan-Feb Impact factor: 6.447

Review 4. Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors: G Powis; M M Ames; J S Kovach
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

Review 5. The antifolates.

Authors: Michele Visentin; Rongbao Zhao; I David Goldman
Journal: Hematol Oncol Clin North Am Date: 2012-06 Impact factor: 3.722

6. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).

Authors: Michele Visentin; Ersin Selcuk Unal; Mitra Najmi; Andras Fiser; Rongbao Zhao; I David Goldman
Journal: Am J Physiol Cell Physiol Date: 2015-01-21 Impact factor: 4.249

Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.

1. A pharmacokinetic model for high-dose methotrexate infusions in man.

2. Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Review 3. Clinical pharmacokinetics of methotrexate.

Review 4. Dose-dependent pharmacokinetics and cancer chemotherapy.

Review 5. The antifolates.

6. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).

7. Mathematical modeling -- guide to high-dose methotrexate infusion therapy.

Review 8. Pharmacokinetics of anticancer drugs in children.

9. Dose dependent methotrexate elimination following bolus intravenous injection.

10. Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma.